This site is intended for Healthcare Professionals only.

Tag: VPAS rate

spot_imgspot_img

Record number of medicines face supply issues amidst spiralling VPAS rebate, warns BGMA

Rising generic medicine supply issues impact four out of five NHS prescriptions The British Generic Manufacturers’ Association (BGMA) has renewed its criticism of the government's...

BGMA advocates ‘tailored’ approach to Statutory Scheme for branded medicines 

The British Generic Manufacturers Association (BGMA) has backed the UK government's proposed changes to the Statutory Scheme for branded medicines, which includes a ‘Life...

Report: NHS faces over £1 billion loss as 85 biologics go off-patent in five years

The NHS is on track to miss out on savings of over a billion pounds as patents for a new lineup of 85 biologics...

BGMA Warns of significant implications from crippling VPAS rate

The British Generic Manufacturers Association (BGMA) has warned of the significant implications for future supply as a result of the crippling VPAS rate. The warning...

Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform

The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...